Dimensional Fund Advisors LP Enzo Biochem Inc Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Enzo Biochem Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 295,677 shares of ENZ stock, worth $153,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
295,677
Previous 304,492
2.89%
Holding current value
$153,752
Previous $341,000
38.71%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ENZ
# of Institutions
50Shares Held
16.6MCall Options Held
18.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.69 Million1.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.37MShares$1.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$966,6810.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$770,5053.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$693,9299.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $25.3M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...